The BRCA1/2-directed miRNA signature predicts a good prognosis in ovarian cancer patients with wild-type BRCA1/2.

Oncotarget · 2015 · PMC4385859 · PMID 25537514

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

fell short of significanceno p-value reported

We found that although the genes BRCA1 and BRCA2 trended toward being down-regulated in the miRNA-related low-risk group compared with the poor prognosis group, this fell short of significance.

also in 361 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.